The clinical incidence of neutralising factors in patients who received ViraferonPeg 0.5 micrograms/kg is 1.1%.
Neutraliseerivate faktorite esinemissagedus oli 1, 1% nendel patsientidel, kes said ViraferonPeg’ i annuses 0, 5 μg/ kg.